|
|||||
|
|
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC |
|
| Authors: | Luke H Stockwin Sherry X Yu Howard Stotler Melinda G Hollingshead Dianne L Newton |
| Affiliation: | (1) Developmental Therapeutics Program, SAIC-Frederick Inc., NCI- Frederick, 21702 Frederick, MD, USA;(2) Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, NCI- Frederick, 21702 Frederick, Maryland, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |